Javascript must be enabled to continue!
ROLE OF CHEMOKINE RECEPTOR 2 IN RENAL INJURY DURING DOCA-SALT HYPERTENSION
View through CrossRef
Objectives
This study was designed to determine the role of chemokine receptor 2 (CCR2), a receptor of MCP-1, in the development of salt-sensitive hypertension-induced renal damage.
Methods
We induced hypertension by uninephrectomy and deoxycorticosterone (DOCA)-salt in C57BL/6 mice with or without a selective CCR2 antagonist, RS504393. Sham mice underwent uninephrectomy without receiving DOCA and saline.
Results
After 4 week treatment, systolic blood pressure (SBP) measured by tail-cuff method increased in the DOCA-salt-treated mice compared with the sham mice (142±7 vs 107±6 mm Hg, p<0.01). DOCA-salt treatment also induced renal hypertrophy, increased urinary albumin and 8-isoprostane excretion and decreased creatinine clearance compared with the sham mice (110.9±3.0 vs 75.6±1.9 mg/10 g body weight; 25.6±2.8 vs 5.7±0.4 µg/24 h; 1.63±0.22 vs 0.51±0.05 ng/24 h; 211±13 vs 336±17 ml/24 h, p<0.05). Periodic acid-Schiff staining showed that DOCA-salt treatment caused obvious glomerulosclrosis compared with the sham mice (0.41±0.05 vs 0.10±0.03, p<0.05). Masson trichrome staining revealed that tubulointerstitial injury in kidney also increased in the DOCA-salt-treated mice compared with the sham mice (2.29±0.36 vs 0.43±0.20, p<0.05). Immunostaining studies showed that DOCA-salt treatment increased monocyte/macrophage infiltration in kidney compared with the sham mice (43±4 vs 13±2 cells/mm2, p<0.05). Blockade of the CCR2 with RS504393 (4 mg/kg/day, sc) had no effect on SBP. However, they prevented renal morphological damage and inhibited the increase in urinary albumin and 8-isoprostane excretion and the decrease in creatinine clearance (p<0.05).
Conclusions
Our data showed that blockade of CCR2 with RS504393 prevented renal damage induced by DOCA-salt hypertension independently of their effects on blood pressure. The results suggest that CCR2-mediated monocyte/macrophage infiltration may contribute to renal damage induced by salt-sensitive hypertension.
Title: ROLE OF CHEMOKINE RECEPTOR 2 IN RENAL INJURY DURING DOCA-SALT HYPERTENSION
Description:
Objectives
This study was designed to determine the role of chemokine receptor 2 (CCR2), a receptor of MCP-1, in the development of salt-sensitive hypertension-induced renal damage.
Methods
We induced hypertension by uninephrectomy and deoxycorticosterone (DOCA)-salt in C57BL/6 mice with or without a selective CCR2 antagonist, RS504393.
Sham mice underwent uninephrectomy without receiving DOCA and saline.
Results
After 4 week treatment, systolic blood pressure (SBP) measured by tail-cuff method increased in the DOCA-salt-treated mice compared with the sham mice (142±7 vs 107±6 mm Hg, p<0.
01).
DOCA-salt treatment also induced renal hypertrophy, increased urinary albumin and 8-isoprostane excretion and decreased creatinine clearance compared with the sham mice (110.
9±3.
0 vs 75.
6±1.
9 mg/10 g body weight; 25.
6±2.
8 vs 5.
7±0.
4 µg/24 h; 1.
63±0.
22 vs 0.
51±0.
05 ng/24 h; 211±13 vs 336±17 ml/24 h, p<0.
05).
Periodic acid-Schiff staining showed that DOCA-salt treatment caused obvious glomerulosclrosis compared with the sham mice (0.
41±0.
05 vs 0.
10±0.
03, p<0.
05).
Masson trichrome staining revealed that tubulointerstitial injury in kidney also increased in the DOCA-salt-treated mice compared with the sham mice (2.
29±0.
36 vs 0.
43±0.
20, p<0.
05).
Immunostaining studies showed that DOCA-salt treatment increased monocyte/macrophage infiltration in kidney compared with the sham mice (43±4 vs 13±2 cells/mm2, p<0.
05).
Blockade of the CCR2 with RS504393 (4 mg/kg/day, sc) had no effect on SBP.
However, they prevented renal morphological damage and inhibited the increase in urinary albumin and 8-isoprostane excretion and the decrease in creatinine clearance (p<0.
05).
Conclusions
Our data showed that blockade of CCR2 with RS504393 prevented renal damage induced by DOCA-salt hypertension independently of their effects on blood pressure.
The results suggest that CCR2-mediated monocyte/macrophage infiltration may contribute to renal damage induced by salt-sensitive hypertension.
Related Results
Inhibition of NLRP3 attenuates DOCA-Salt-Induced Hypertrophy and
Endothelial Dysfunction in Male But Not Female Rats
Inhibition of NLRP3 attenuates DOCA-Salt-Induced Hypertrophy and
Endothelial Dysfunction in Male But Not Female Rats
The immune system has been implicated in the development of
hypertension and how the immune system is activated is of high interest. The
...
The bovine chemokine receptors and their mRNA abundance in mononuclear phagocytes
The bovine chemokine receptors and their mRNA abundance in mononuclear phagocytes
AbstractBackgroundThe chemokine and chemokine receptor families play critical roles in both the healthy and diseased organism mediating the migration of cells. The chemokine system...
Plasma atrial natriuretic peptide in DOCA‐NaCl‐treated rats
Plasma atrial natriuretic peptide in DOCA‐NaCl‐treated rats
In order to assess the possible role of atrial natriuretic peptide (ANP) in the development of deoxycorticosterone (DOCA)‐NaCl‐induced hypertension, plasma immunoreactive ANP conce...
Pressure Natriuresis in Salt-Sensitive and Salt-Resistant Sabra Rats
Pressure Natriuresis in Salt-Sensitive and Salt-Resistant Sabra Rats
Abstract
Salt-resistant (SBN/y) and salt-sensitive (SBH/y) Sabra rats are a useful model of salt-sensitive hypertension with incompletely explored renal mechanisms. We ...
Renal serotonin signaling in ischemic kidney insufficiency
Renal serotonin signaling in ischemic kidney insufficiency
Renal ischemia–reperfusion (IR) injury is a major cause of acute kidney injury (AKI), a syndrome associated with high morbidity, mortality, and long-term risk of chronic kidney dis...
Cannabinoid Administration Does Not Affect Mean Arterial Pressure or Glomerular Filtration Rate in DOCA‐Salt Hypertensive Rats
Cannabinoid Administration Does Not Affect Mean Arterial Pressure or Glomerular Filtration Rate in DOCA‐Salt Hypertensive Rats
Hypertension remains the leading cause of cardiovascular disease – the leading cause of morbidity and mortality worldwide, and effective pharmacological options remain limited. Rec...
Role of endothelin and vasopressin in DOCA‐salt hypertension
Role of endothelin and vasopressin in DOCA‐salt hypertension
The relative roles of endothelin (ET) and vasopressin (AVP) in the regulation of blood pressure (BP), cardiac output (CO) and total peripheral resistance (TPR) were investigated in...
GW24-e3137 The etiology investigate of hypertension incidence in children
GW24-e3137 The etiology investigate of hypertension incidence in children
Objectives
Through retrospective analysis of related factors of children’s hypertension what is composed by primary hypertension and secondary hypertension diseas...

